Health
Covid vaccine: Moderna targets emergency approval in December – Mint
In July, Moderna started a 30,000-person study in the US to test its covid vaccine candidate
US-based Moderna expects interim results of its covid vaccine trials next month. And if the company gets positive interim results from the large clinical trial, the US government could authorize emergency use of the companys experimental Covid-19 vaccine in December, its chief executive said.Speaking during The Wall Street Journals annual Tech Live conference on Monday, Chief Executive Stephane Bancel said if sufficient interim results from the study takes longer to get, government authorization…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News24 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?